ATE201598T1 - Verwendung von moxonidin zur behandlung neuropathischer schmerzen - Google Patents

Verwendung von moxonidin zur behandlung neuropathischer schmerzen

Info

Publication number
ATE201598T1
ATE201598T1 AT98117344T AT98117344T ATE201598T1 AT E201598 T1 ATE201598 T1 AT E201598T1 AT 98117344 T AT98117344 T AT 98117344T AT 98117344 T AT98117344 T AT 98117344T AT E201598 T1 ATE201598 T1 AT E201598T1
Authority
AT
Austria
Prior art keywords
moxonidine
neuropathic pain
treat neuropathic
treatment
composition
Prior art date
Application number
AT98117344T
Other languages
English (en)
Inventor
Carolyn A Fairbanks
George L Wilcox
Tinna M Laughlin
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of ATE201598T1 publication Critical patent/ATE201598T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98117344T 1997-09-16 1998-09-14 Verwendung von moxonidin zur behandlung neuropathischer schmerzen ATE201598T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5902197P 1997-09-16 1997-09-16

Publications (1)

Publication Number Publication Date
ATE201598T1 true ATE201598T1 (de) 2001-06-15

Family

ID=22020310

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98117344T ATE201598T1 (de) 1997-09-16 1998-09-14 Verwendung von moxonidin zur behandlung neuropathischer schmerzen

Country Status (8)

Country Link
US (1) US6054461A (de)
EP (1) EP0901790B1 (de)
AT (1) ATE201598T1 (de)
DE (1) DE69800859T2 (de)
DK (1) DK0901790T3 (de)
ES (1) ES2157107T3 (de)
GR (1) GR3036071T3 (de)
PT (1) PT901790E (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559186B1 (en) 1990-02-26 2003-05-06 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
DE19911371A1 (de) * 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
US7015371B2 (en) * 2001-03-07 2006-03-21 Mary Hannaman Romans Non-traumatic model for neurogenic pain
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
CA2487541A1 (en) * 2002-06-19 2003-12-31 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
KR20050094843A (ko) * 2003-01-13 2005-09-28 다이노젠 파마세우티컬스, 인코포레이티드 욕지기, 구토, 구역질 또는 이들의 조합을 치료하는 방법
EP2286817A3 (de) * 2003-01-13 2011-06-15 Edusa Pharmaceuticals, Inc Verfahren zur Behandlung von funktionalen Darmerkrankungen
WO2004071421A2 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Sustained release formulation of n-(2-propylpentanoyl) glycinamide and related compounds
WO2004071424A2 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries, Ltd. Immediate release formulation of n-(2-propylpentanoyl)glycinamide
EP1613324A2 (de) * 2003-04-14 2006-01-11 Pain Therapeutics, Inc. Verfahren zur behandlung von schmerzen mit opioid-antagonisten
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
CN101365445A (zh) * 2005-11-08 2009-02-11 弧离子治疗公司 对长度依赖性神经病的治疗
US8026266B2 (en) 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US7964585B2 (en) * 2006-03-14 2011-06-21 Case Western Reserve University Composition and method of treating peripheral neuropathy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014453A1 (en) * 1991-02-26 1992-09-03 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain

Also Published As

Publication number Publication date
DE69800859T2 (de) 2001-09-27
EP0901790B1 (de) 2001-05-30
DE69800859D1 (de) 2001-07-05
EP0901790A1 (de) 1999-03-17
US6054461A (en) 2000-04-25
PT901790E (pt) 2001-09-28
ES2157107T3 (es) 2001-08-01
DK0901790T3 (da) 2001-08-06
GR3036071T3 (en) 2001-09-28

Similar Documents

Publication Publication Date Title
ATE164067T1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
DE69616376D1 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
PL309596A1 (en) Application of anticonvulsant agents in treating parkinson disease and parkinsonian syndromes
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
BG106118A (en) Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
DE69310528D1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
FI971127A0 (fi) 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
BR9708037A (pt) Método para o tratamento de abuso de substância
SE9002731D0 (sv) Product comprising growth factor
EE04951B1 (et) R-(+)-alfa-(2,3-dimetoksfenl)-1-[2-(4-fluorofenl)etl]-4-piperidiinmetanooli kasutamine uneh„irete raviks
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
UA36490A (uk) Спосіб лікування гнійно-септичних захворювань м'яких тканин

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee